Karyopharm Therapeutics
KPTI
KPTI
85 hedge funds and large institutions have $285M invested in Karyopharm Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
85
Holding in Top 10
–
Calls
$2.38M
Puts
$1.91M
Top Buyers
| 1 | +$3.56M | |
| 2 | +$1.81M | |
| 3 | +$1.64M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$630K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$600K |
Top Sellers
| 1 | -$7.51M | |
| 2 | -$7.36M | |
| 3 | -$5.91M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$5.55M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.17M |